Orion OyjORINF +4.81%100 Interest Coverage is 81.95 as of Mar. 2026, which is 17% above its 10-year median of 70.12. GuruFocus rates ORINF with a GF Score™ of 100/100 and a GF Value™ of $86.78. The stock has 2 warning signs investors should review. Among 685 Drug Manufacturers companies, Orion Oyj ranks better than 83.5% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Orion Oyj's
Operating Income
for the
three
months ended in Mar. 2026 was $133 Mil. Orion Oyj's Interest Expense for the
three
months ended in Mar. 2026 was $-2 Mil.
Orion Oyj's interest coverage for the quarter that ended in Mar. 2026 was 81.95.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Orion Oyj's Interest Coverage or its related term are showing as below:
ORINF'
s Interest Coverage Range Over the Past 10 Years
Min: 51 Med: 70.12 Max: 307.11
Current: 155.49
ORINF's Interest Coverage is ranked better than 83.5% of 685
companies
in the Drug Manufacturers industry
Industry Median: 12.78
vs ORINF: 155.49
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Orion Oyj Interest Coverage Related Terms
Orion Oyj Interest Coverage Historical Data
* Premium members only.
The historical data trend for Orion Oyj's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
ORINF vs LLY, JNJ, ABBV: Interest Coverage Comparison
For the Drug Manufacturers - General subindustry, Orion Oyj's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orion Oyj Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Orion Oyj's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Orion Oyj's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orion Oyj (ORINF) has a Interest Coverage of 81.95 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Orion Oyj and its competitors. This is 17% above median its historical median of 70.12. Over the past decade, Orion Oyj's Interest Coverage has ranged from 51.00 to 307.11. According to the industry distribution chart, Orion Oyj ranks #113 out of 685 companies in the Drug Manufacturers industry, placing it in the top 16.5%.
Is Orion Oyj's Interest Coverage too high?
Orion Oyj's current Interest Coverage of 81.95 is 17% above median its 10-year median of 70.12. Over the past 10 years, this metric has ranged from a low of 51.00 to a high of 307.11. The Drug Manufacturers industry median Interest Coverage is 12.78. Orion Oyj's value of 81.95 is 541.2% above this industry median. Based on the distribution chart, Orion Oyj ranks #113 out of 685 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Orion Oyj has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Orion Oyj's Interest Coverage compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Orion Oyj ranks #113 out of 685 companies for Interest Coverage. This places Orion Oyj in the top 17% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 12.78. Orion Oyj's value of 81.95 is 541.2% above this benchmark. Historically, Orion Oyj's own Interest Coverage has ranged from 51.00 to 307.11 over the past decade. While the company's 10-year median is 70.12 vs. the industry median of 12.78, Orion Oyj has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.78, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orion Oyj's current Interest Coverage of 81.95 is 541.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Orion Oyj and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orion Oyj's current Interest Coverage is 81.95, which is 17% above median its own 10-year median of 70.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orion Oyj stock overvalued right now?
Orion Oyj (ORINF) has a current Interest Coverage of 81.95. The stock's GF Value™ is $86.78, compared to a current price of $82.75 — trading 4.6% below its estimated fair value. The current Interest Coverage is 81.95, which is 17% above median its 10-year median of 70.12 and 541.2% above the Drug Manufacturers industry median of 12.78. Orion Oyj's overall GF Score™ is 100/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Orion Oyj (ORINF), the current Interest Coverage is 81.95 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orion Oyj (ORINF) Overvalued in 2026?
Based on GuruFocus' analysis, Orion Oyj stock appears to be undervalued.
The current stock price of $82.75 is trading 4.6% below its estimated GF Value™ of $86.78.
Key valuation signals for ORINF:
Interest Coverage: 81.95 (17% above median its 10-year median of 70.12)
GF Value™: $86.78 vs. price of $82.75 (4.6% below fair value)
Industry Position: 541.2% above the Drug Manufacturers median (#113 of 685)
No single metric tells the full story. See the ORINF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. The company mainly serves Finland but also has a presence in other European countries, North America and other countries.
100GF Score
Get the complete analysis for ORINF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ORINF has been successfully added to your 
